Prospects for a novel vaccine against tuberculosis

Veterinary Microbiology

Volumn 112, Issue 2-4 SPEC. ISS., 2006, Pages 163-169

  Dietrich, Jes ^a   Weldingh, Karin ^a   Andersen, Peter ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

Bacterial; Tuberculosis; Vaccination

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL VACCINE; BCG VACCINE; HYBRID PROTEIN;

AG85 ANTIGEN; ANTIGEN RECOGNITION; BACTERIAL GENOME; BCG VACCINATION; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG MECHANISM; ESAT6 ANTIGEN; FUSION GENE; HUMAN; IMMUNE RESPONSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; TB10.4 ANTIGEN; TUBERCULOSIS; VACCINE FAILURE;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BCG VACCINE; CATTLE; DRUG DESIGN; HUMANS; IMMUNIZATION, SECONDARY; INDOLES; MICE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; TUBERCULOSIS VACCINES;

ANIMALIA; BACTERIA (MICROORGANISMS); MYCOBACTERIUM TUBERCULOSIS; PRIMATES;

EID: 31844452949     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2005.11.030     Document Type: Conference Paper

References (56)

1. M.R. Alderson, T. Bement, C.H. Day, L. Zhu, D. Molesh, Y.A. Skeiky, R. Coler, D.M. Lewinsohn, S.G. Reed, and D.C. Dillon Expression cloning of an immunodominant family of Mycobacterium tuberculosis antigens using human CD4(+) T cells J. Exp. Med. 191 2000 551 560
2. F.A. al-Kassimi, M.S. al-Hajjaj, I.O. al-Orainey, and E.A. Bamgboye Does the protective effect of neonatal BCG correlate with vaccine-induced tuberculin reaction. Does the protective effect of neonatal BCG correlate with vaccine-induced tuberculin reaction Am. J. Respir. Crit. Care Med. 152 1995 1575 1578
3. P. Andersen Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins Infect. Immun. 62 1994 2536 2544
4. P. Andersen The T cell response to secreted antigens of Mycobacterium tuberculosis Immunobiology 191 1994 537 547
5. P. Andersen, A.B. Andersen, A.L. Sorensen, and S. Nagai Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice J. Immunol. 154 1995 3359 3372
6. P. Andersen, D. Askgaard, A. Gottschau, J. Bennedsen, S. Nagai, and I. Heron Identification of immunodominant antigens during infection with Mycobacterium tuberculosis Scand. J. Immunol. 36 1992 823 831
7. P. Andersen, D. Askgaard, L. Ljungqvist, J. Bennedsen, and I. Heron Proteins released from Mycobacterium tuberculosis during growth Infect. Immun. 59 1991 1905 1910
8. P. Andersen, D. Askgaard, L. Ljungqvist, M.W. Bentzon, and I. Heron T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis Infect. Immun. 59 1991 1558 1563
9. Anon., 2002. Global Tuberculosis Control. WHO Report 2002 (Geneva, Switzerland, World Health Organization), p. 181.
10. S.M. Behar, C.C. Dascher, M.J. Grusby, C.R. Wang, and M.B. Brenner Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis J. Exp. Med. 189 1999 1973 1980
11. H. Boesen, B.N. Jensen, T. Wilcke, and P. Andersen Human T-cell responses to secreted antigen fractions of Mycobacterium tuberculosis Infect. Immun. 63 1995 1491 1497
12. L. Brandt, M. Elhay, I. Rosenkrands, E.B. Lindblad, and P. Andersen ESAT-6 subunit vaccination against Mycobacterium tuberculosis Infect. Immun. 68 2000 791 795
13. L. Brandt, J. Feino Cunha, A. Weinreich Olsen, B. Chilima, P. Hirsch, R. Appelberg, and P. Andersen Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis Infect. Immun. 70 2002 672 678
14. T.F. Brewer Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature Clin. Infect. Dis. 31 Suppl. 3 2000 S64 S67
15. I. Brock, K. Weldingh, E.M. Leyten, S.M. Arend, P. Ravn, and P. Andersen Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection J. Clin. Microbiol. 42 2004 2379 2387
16. G.A. Colditz, C.S. Berkey, F. Mosteller, T.F. Brewer, M.E. Wilson, E. Burdick, and H.V. Fineberg The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature Pediatrics 96 1995 29 35
17. G.A. Colditz, T.F. Brewer, C.S. Berkey, M.E. Wilson, E. Burdick, H.V. Fineberg, and F. Mosteller Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature JAMA 271 1994 698 702
18. A.M. Cooper, D.K. Dalton, T.A. Stewart, J.P. Griffin, D.G. Russell, and I.M. Orme Disseminated tuberculosis in interferon gamma gene-disrupted mice J. Exp. Med. 178 1993 2243 2247
19. J. Dietrich, C. Aagaard, R. Leah, A.W. Olsen, A. Stryhn, T.M. Doherty, and P. Andersen Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy J. Immunol. 174 2005 6332 6339
20. T.M. Doherty, A.W. Olsen, J. Weischenfeldt, K. Huygen, S. D'Souza, T.K. Kondratieva, V.V. Yeremeev, A.S. Apt, B. Raupach, L. Grode, S.H.E. Kaufmann, and P. Andersen Comparative analysis of different vaccine constructs expressing defined antigens from Mycobacterium tuberculosis J. Infect. Dis. 15 2004 2146 2153
21. S.E. Dorman, and S.M. Holland Interferon-gamma and interleukin-12 pathway defects and human disease Cytokine Growth Factor Rev. 11 2000 321 333
22. C.G. Feng, U. Palendira, C. Demangel, J.M. Spratt, A.S. Malin, and W.J. Britton Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis Infect. Immun. 69 2001 4174 4176
23. P.E. Fine Variation in protection by BCG: implications of and for heterologous immunity Lancet 346 1995 1339 1345
24. J.L. Flynn, J. Chan, K.J. Triebold, D.K. Dalton, T.A. Stewart, and B.R. Bloom An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection J. Exp. Med. 178 1993 2249 2254
25. M.A. Horwitz, G. Harth, B.J. Dillon, and S. Maslesa-Galic Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model Proc. Natl. Acad. Sci. U.S.A. 97 2000 13853 13858
26. T. Hsu, S.M. Hingley-Wilson, B. Chen, M. Chen, A.Z. Dai, P.M. Morin, C.B. Marks, J. Padiyar, C. Goulding, M. Gingery, D. Eisenberg, R.G. Russell, S.C. Derrick, F.M. Collins, S.L. Morris, C.H. King, and W.R. Jacobs Jr. The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue Proc. Natl. Acad. Sci. U.S.A. 100 2003 12420 12425
27. R.D. Hubbard, C.M. Flory, and F.M. Collins Immunization of mice with mycobacterial culture filtrate proteins Clin. Exp. Immunol. 87 1992 94 98
28. K. Huygen, J. Content, O. Denis, D.L. Montgomery, A.M. Yawman, R.R. Deck, C.M. DeWitt, I.M. Orme, S. Baldwin, C. D'Souza, A. Drowart, E. Lozes, P. Vandenbussche, J.P. Van-Vooren, M.A. Liu, and J.B. Ulmer Immunogenecity and protective efficacy of a tuberculosis DNA vaccine Nat. Med. 2 1996 893 898
29. A.T. Kamath, C.G. Feng, M. Macdonald, H. Briscoe, and W.J. Britton Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis Infect. Immun. 67 1999 1702 1707
30. A. Lalvani, A.A. Pathan, H. McShane, R.J. Wilkinson, M. Latif, C.P. Conlon, G. Pasvol, and A.V. Hill Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells Am. J. Respir. Crit. Care Med. 163 2001 824 828
31. C. Lanckriet, D. Levy-Bruhl, E. Bingono, R.M. Siopathis, and N. Guerin Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui Int. J. Epidemiol. 24 1995 1042 1049
32. J.A. Langermans, T.M. Doherty, R.A. Vervenne, T. van der Laan, K. Lyashchenko, R. Greenwald, E.M. Agger, C. Aagaard, H. Weiler, D. van Soolingen, W. Dalemans, A.W. Thomas, and P. Andersen Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6 Vaccine 23 2005 2740 2750
33. Z. Li, A. Howard, C. Kelley, G. Delogu, F. Collins, and S. Morris Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences Infect. Immun. 67 1999 4780 4786
34. E. Lozes, K. Huygen, J. Content, O. Denis, D.L. Montgomery, A.M. Yawman, P. Vandenbussche, J.P. Van-Vooren, A. Drowart, J.B. Ulmer, and M.A. Liu Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex Vaccine 15 1997 830 833
35. H. McShane, A.A. Pathan, C.R. Sander, S.M. Keating, S.C. Gilbert, K. Huygen, H.A. Fletcher, and A.V. Hill Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans Nat. Med. 10 2004 1240 1244
36. T. Mogues, M.E. Goodrich, L. Ryan, R. LaCourse, and R.J. North The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice J. Exp. Med. 193 2001 271 280
37. A.S. Mustafa, F.A. Shaban, A.T. Abal, R. Al-Attiyah, H.G. Wiker, K.E. Lundin, F. Oftung, and K. Huygen Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4(+) T-cell lines Infect. Immun. 68 2000 3933 3940
38. L.M. Okkels, I. Brock, F. Follmann, E.M. Agger, S.M. Arend, T.H. Ottenhoff, F. Oftung, I. Rosenkrands, and P. Andersen PPE protein (Rv3873) from DNA segment RD1 of Mycobacterium tuberculosis: strong recognition of both specific T-cell epitopes and epitopes conserved within the PPE family Infect. Immun. 71 2003 6116 6123
39. A.W. Olsen, L.A. van Pinxteren, L.M. Okkels, P.B. Rasmussen, and P. Andersen Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85b and esat-6 Infect. Immun. 69 2001 2773 2778
40. A.W. Olsen, A. Williams, L.M. Okkels, G. Hatch, and P. Andersen Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model Infect. Immun. 72 2004 6148 6150
41. I.M. Orme The immune response to the cell wall of Mycobacterium bovis BCG Clin. Exp. Immunol. 71 1988 388 393
42. P.G. Pal, and M.A. Horwitz Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis Infect. Immun. 60 1992 4781 4792
43. A.S. Pym, P. Brodin, L. Majlessi, R. Brosch, C. Demangel, A. Williams, K.E. Griffiths, G. Marchal, C. Leclerc, and S.T. Cole Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis Nat. Med. 9 2003 533 539
44. P. Ravn, A. Demissie, T. Eguale, H. Wondwosson, D. Lein, H. Amoudy, A.S. Mustafa, A.K. Jensen, A. Holm, I. Rosenkrands, F. Oftung, J. Olobo, C.F. von-Reyn, and P. Andersen Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis J. Infect. Dis. 179 1999 637 645
45. P.S. Renshaw, P. Panagiotidou, A. Whelan, S.V. Gordon, R.G. Hewinson, R.A. Williamson, and M.D. Carr Conclusive evidence that the major T-cell antigens of the Mycobacterium tuberculosis complex ESAT-6 and CFP-10 form a tight, 1:1 complex and characterization of the structural properties of ESAT-6, CFP-10, and the ESAT-6-CFP-10 complex. Implications for pathogenesis and virulence J. Biol. Chem. 277 2002 21598 21603
46. P.W. Roche, P.W. Peake, H. Billman-Jacobe, T. Doran, and W.J. Britton T-cell determinants and antibody binding sites on the major mycobacterial secretory protein MPB59 of Mycobacterium bovis Infect. Immun. 62 1994 5319 5326
47. U.E. Schaible, and S.H. Kaufmann CD1 and CD1-restricted T cells in infections with intracellular bacteria Trends Microbiol. 8 2000 419 425
48. R.F. Silver, R.S. Wallis, and J.J. Ellner Mapping of T cell epitopes of the 30-kDa alpha antigen of Mycobacterium bovis strain bacillus Calmette-Guerin in purified protein derivative (PPD)-positive individuals J. Immunol. 154 1995 4665 4674
49. R.L. Skjot, I. Brock, S.M. Arend, M.E. Munk, M. Theisen, T.H. Ottenhoff, and P. Andersen Epitope mapping of the immunodominant antigen TB10.4 and the two homologous proteins TB10.3 and TB12.9, which constitute a subfamily of the esat-6 gene family Infect. Immun. 70 2002 5446 5453
50. R.L. Skjot, T. Oettinger, I. Rosenkrands, P. Ravn, I. Brock, S. Jacobsen, and P. Andersen Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens Infect. Immun. 68 2000 214 220
51. A.L. Sorensen, S. Nagai, G. Houen, P. Andersen, and A.B. Andersen Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis Infect. Immun. 63 1995 1710 1717
52. J.A. Sterne, L.C. Rodrigues, and I.N. Guedes Does the efficacy of BCG decline with time since vaccination? Int. J. Tuberc. Lung Dis. 2 1998 200 207
53. R.E. Tascon, E. Stavropoulos, K.V. Lukacs, and M.J. Colston Protection against Mycobacterium tuberculosis infection by CD8+ T cells requires the production of gamma interferon Infect. Immun. 66 1998 830 834
54. J. Turner, C.D. D'Souza, J.E. Pearl, P. Marietta, M. Noel, A.A. Frank, R. Appelberg, I.M. Orme, and A.M. Cooper CD8- and CD95/95L-dependent mechanisms of resistance in mice with chronic pulmonary tuberculosis Am. J. Respir. Cell. Mol. Biol. 24 2001 203 209
55. L. van Pinxteren, J.P. Cassidy, B.H.C. Smedegaard, E.M. Agger, and P. Andersen Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells Eur. J. Immunol. 30 2000 3689 3698
56. B.J. Wards, G.W. de Lisle, and D.M. Collins An esat6 knockout mutant of Mycobacterium bovis produced by homologous recombination will contribute to the development of a live tuberculosis vaccine Tuberc. Lung Dis. 80 2000 185 189